China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition

MT Newswires Live

2025/02/07

China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.

The deal involves purchasing shares from seven entities.

The transaction is subject to board and shareholder approvals.

Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2509765996"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509765996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509765996?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-07 13:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509765996","market":"hk","top_or_hot":-1,"title":"China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition","media":"MT Newswires Live","content":"<html><body><p> China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.</p><p>The deal involves purchasing shares from seven entities.</p><p>The transaction is subject to board and shareholder approvals.</p><p>Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-07 13:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.</p><p>The deal involves purchasing shares from seven entities.</p><p>The transaction is subject to board and shareholder approvals.</p><p>Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二线龙头","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509765996","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509765996","pubTimestamp":1738907237,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Sanjiu  received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group , according to filings with the Shanghai and Shenzhen bourses.The deal involves purchasing shares from seven entities.The transaction is subject to board and shareholder approvals.Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600535":"天士力","BK0185":"二线龙头","BK0183":"MSCI概念","BK0010":"央企","BK0188":"融资融券","BK0239":"医药制造","BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","BK0060":"抗癌","000999":"华润三九","BK0028":"国家队"},"translate_title":"华润三九天士力药业股权收购获国资委批复","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":0.9,"000999":0.9},"content_text":"China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.The deal involves purchasing shares from seven entities.The transaction is subject to board and shareholder approvals.Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}